[
    [
        {
            "time": "2018-03-01",
            "original_text": "Bristol-Myers Squibb’s Valuation in March 2018",
            "features": {
                "keywords": [
                    "Bristol-Myers",
                    "Squibb",
                    "valuation"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Bristol-Myers Squibb’s Valuation in March 2018",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "When Will They Learn? 4 Huge Biotech Blowups",
            "features": {
                "keywords": [
                    "biotech",
                    "blowups"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "When Will They Learn? 4 Huge Biotech Blowups",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "AbbVie a Top Ranked SAFE Dividend Stock With 4.2% Yield (ABBV)",
            "features": {
                "keywords": [
                    "AbbVie",
                    "dividend",
                    "yield"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie a Top Ranked SAFE Dividend Stock With 4.2% Yield (ABBV)",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "It's Not Final 4 But WashU, Wisconsin Fight on Other Court",
            "features": {
                "keywords": [
                    "WashU",
                    "Wisconsin",
                    "fight",
                    "court"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "It's Not Final 4 But WashU, Wisconsin Fight on Other Court",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 2,
                "Impact": 1,
                "Duration": 1,
                "Entity_Density": 1,
                "Market_Scope": 1,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "3 Biotechs That Could Get Big Boosts in April",
            "features": {
                "keywords": [
                    "biotechs",
                    "boosts",
                    "April"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3 Biotechs That Could Get Big Boosts in April",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-28",
            "original_text": "Validea Peter Lynch Strategy Daily Upgrade Report - 3/28/2018",
            "features": {
                "keywords": [
                    "Validea",
                    "Peter Lynch",
                    "strategy",
                    "upgrade"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Validea Peter Lynch Strategy Daily Upgrade Report - 3/28/2018",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "Biotech Stocks Facing FDA Decision In April",
            "features": {
                "keywords": [
                    "biotech",
                    "FDA",
                    "decision"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Biotech Stocks Facing FDA Decision In April",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]